Welcome to our dedicated page for Ambev SEC filings (Ticker: ABEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ambev S.A. (ABEV) SEC filings page brings together the company’s disclosures as a foreign private issuer with securities listed on the New York Stock Exchange. Ambev files an annual report on Form 20-F, as highlighted in multiple press releases announcing the availability of its annual reports for successive years. These 20-F filings contain the company’s complete audited financial statements, and the press releases note that American Depositary Receipt holders may request hard copies free of charge.
In addition to its annual reports, Ambev regularly furnishes Form 6-K current reports. The examples provided include notices to shareholders about ordinary shareholders’ meetings, extracts of minutes from Board of Directors meetings, and detailed explanations of decisions to distribute dividends and interest on capital based on extraordinary balance sheets. Other 6-Ks disclose policies on executive remuneration and the grant of stock options and restricted shares, as well as a policy on hiring services related or not related to auditing, which sets conditions for engaging independent auditors and lists non-authorized services to preserve auditor independence.
Ambev also uses Form 6-K to report related party transactions, such as its agreement with its controlling shareholder Anheuser-Busch InBev SA/NV for the use of the BEES B2B digital platform, and to provide consolidated and individual forms under Article 11 of CVM Instruction 358/2002 that detail management and related persons’ transactions in Ambev shares and ADRs. These forms show initial and final positions, deliveries of restricted shares, purchases, and sales.
On Stock Titan, these filings can be paired with AI-powered summaries that explain the key points of lengthy documents, highlight items such as dividend approvals, interest on capital distributions, insider share movements, and policy changes, and help readers navigate Ambev’s 20-F and 6-K disclosures more efficiently.
Ambev S.A. filed its annual report on Form 20-F for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission. The report is available on Ambev’s investor relations website and on the SEC’s EDGAR system. Holders of Ambev ADRs can request a hard copy of the complete audited financial statements contained in the Form 20-F free of charge.
Ambev S.A. filed its annual Form 20-F for the year ended December 31, 2025, covering its Brazilian and international beer and non-alcoholic beverage operations.
The company prepares consolidated financial statements under IFRS in reais and translates certain figures using a rate of R$5.50 per US$1.00. It had 15,761,638,756 common shares outstanding as of year-end, and net revenues of R$88.2 billion, with 44.4% generated by foreign subsidiaries.
The report focuses heavily on risk factors, including exposure to exchange-rate swings that affect U.S. dollar–linked packaging and ingredient costs, commodity price volatility, IT and cybersecurity threats, tightening data-protection rules, and growing litigation and tax uncertainties in Brazil and other markets.
Ambev also describes potential impacts from Brazilian consumption-tax reform, global minimum tax rules, higher IOF and new dividend withholding, as well as U.S. protectionist trade measures and tariffs that could influence input costs, exports and overall profitability.
Ambev S.A. reports that, according to its latest earnings release, it expects Cash COGS per hectoliter for its beer business in Brazil to increase between 4.5%-7.5% for the full year of 2026. This projection excludes the sale of non-Ambev products on the marketplace and assumes current commodity prices and exchange rates.
The expected increase is mainly linked to commodity-related costs, especially aluminum, and to portfolio mix. Ambev stresses this is a management projection, not a performance promise, is subject to risks and uncertainties, and the 2026 information is preliminary and not yet reviewed by external auditors.
Ambev S.A. filed a 6-K stating that its Fiscal Council examined the independent auditor’s report, issued without qualification by Grant Thornton, and a performance report from the Chief Financial, Investor Relations and Shared Services Officer. The council expressed a favorable opinion on approving the Management Report, the financial statements for the year ended December 31, 2025, and the proposed allocation of net income, including dividends and interest on own capital as described in those statements.
Ambev S.A. reported 2025 fourth quarter and full-year results showing resilient profitability despite lower volumes. For 2025, total volume fell 3.3%, but organic net revenue rose 4.0% as net revenue per hectoliter increased 7.5%, supported by premiumization and revenue management.
Full-year Normalized EBITDA grew 5.6% to R$ 29.5 billion, with EBITDA margin up 50 bps to 33.4%, the third consecutive year of margin expansion. Profit increased 7.7% to R$ 15.99 billion and stated EPS grew 8.2%. Operating cash flow reached R$ 24.5 billion, and Ambev returned R$ 21.7 billion to shareholders on a cash basis, while ending 2025 with net cash of R$ 16.9 billion.
Ambev S.A. will pay the first tranche of interest on own capital to shareholders on April 6, 2026. The payment will be R$0.075 gross per share, which corresponds to R$0.063 net per share after Brazilian income tax.
The distribution was originally approved on December 9, 2025. Record dates remain December 18, 2025 for holders on B3 in Brazil and December 22, 2025 for holders on the NYSE, with shares and ADRs trading ex-IOC from December 19, 2025. The payment date for the remaining approved amount will be decided by the board by December 31, 2026.
Ambev S.A. filed a foreign issuer report stating that in January 2026 it did not carry out any transactions in its own securities or derivatives under the terms of Brazilian Instruction #44/2021. The company confirms its position in treasury shares, holding 145,113,436 common shares and no ADRs as of that reporting month.
Ambev S.A. reports transactions in its own securities by related parties for the period from January 1 to 31, 2026, under Brazilian Instruction 44/2021. The Board of Directors maintained holdings of 30,400,903 common shares and 468,040 ADRs, with no share movements in the month.
Management began the month with 5,822,022 common shares and 19,790 ADRs and ended with 5,208,794 common shares and 19,790 ADRs, reflecting a net decrease of 613,228 common shares after a series of sales, purchases, and securities lending operations mainly executed through XP Corretora and XP Investimentos S/A. The Fiscal Council held 2,500 common shares throughout the month with no transactions reported.